| 70458-95-6 |
3-carboxy-1-ethyl-6-fluoro-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxoquinoline monomethanesulphonate |
Pefloxacin Mesylate; 1-Ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid monomethanesulfonate; 1-ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid methanesulfonate (1:1); Pefloxacin Methane Sulphonate |
C18H24FN3O6S |
5
supplier(s)
70458-95-6 |
| 70458-96-7 |
norfloxacin |
Norfloxacine; 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid; 2-hydroxypropanoic acid |
C16H18FN3O3 |
20
supplier(s)
70458-96-7 |
| 7047-84-9 |
dihydroxyaluminium stearate |
|
C18H40AlO4 |
1
supplier(s)
7047-84-9 |
| 70476-82-3 |
Mitoxantrone hydrochloride |
Mitoxantrone hcl; 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthracene-9,10-dione dihydrochloride |
C22H31Cl3N4O6 |
4
supplier(s)
70476-82-3 |
| 7048-4-6 |
L-Cysteine hydrochloride monohydrate |
L-cysteine hcl monohydrate; H-Cys-OH.HCl.H2O; H-Cys-OH.HCl.H_2O; L-Cysteine Hcl Mono; L-cysteine hydrochloride hydrate; L-Cystene Hydrochloride Monohydrate |
C3H10ClNO3S |
4
supplier(s)
7048-4-6 |
| 70491-05-3 |
Boc-alpha-Cyclohexyl-D-glycine |
(R)-N-Boc-amino-cyclohexyl-acetic acid; (2R)-[(tert-butoxycarbonyl)amino](cyclohexyl)ethanoic acid |
C13H23NO4 |
0
supplier(s)
70491-05-3 |
| 705-15-7 |
1-(2-hydroxy-5-methoxyphenyl)ethan-1-one |
|
C9H10O3 |
1
supplier(s)
705-15-7 |
| 705-21-5 |
3,5-Dichlorobenzenesulfonyl chloride |
3,5-Dichlorobenzene-1-sulfonyl chloride; 3,5-Dichlorobenzenesulphonyl chloride |
C6H3Cl3O2S |
1
supplier(s)
705-21-5 |
| 705-29-3 |
Alpha'-Chloro-Alpha,Alpha,Alpha-trifluoro-m-xylene |
3-Chloromethylbenzotrifluoride; 3-(Trifluoromethyl)benzyl chloride; 1-(Chloromethyl)-3-(trifluoromethyl)benzene |
C8H6ClF3 |
1
supplier(s)
705-29-3 |
| 705-60-2 |
2-Nitro-1-phenylpropene |
1-Phenyl-2-nitropropene |
C9H9NO2 |
1
supplier(s)
705-60-2 |
Pharma Sources Insight July 2025
